Robert
W. Doms, Ph.D.
Professor,
Department of Pathology
and Laboratory Medicine
School of Medicine
806 Abramson Building
(215) 898-0890 FAX: (215) 573-2883
email: doms@mail.med.upenn.edu
Lorem ipsum
Click here for selected publications since Dr. Doms's arrival at Penn
RESEARCH INTERESTS
Cell biology of membrane proteins involved in Alzheimer's disease pathogenesis;
Viral neuropathogenesis
RESEARCH TECHNIQUES
Viral vectors, including lentivirus vectors; model in vitro neuronal systems;
molecular biology; cell biological techniques to study protein transport
and processing; studies with HIV-1 and SIV
RESEARCH SUMMARY
Three membrane proteins have been identified that, if they harbor particular
point mutations, inevitably lead to the development of Alzheimer's disease.
These proteins are the amyloid precursor protein (APP), presenilin-1 (PS1)
and presenilin-2 (PS2). An important pathological feature of Alzheimer's
disease is the accumulation of senile plaques composed predominantly of
amyloid-b (Ab) peptide.
The Ab peptide is generated from proteolytic
processing of APP, a type I transmembrane glycoprotein. APP is cleaved by
two distinct enzymatic activities which result in the production of an array
of Ab species that differ only slightly in length
but vary greatly in their abilities to aggregate. In the amyloidgenic pathway,
APP is first cleaved by BACE, which cuts at an extraluminal site generating
a C-terminal APP fragment, and subsequently within its transmembrane domain
by g-secretase to generate Ab
peptides and an intracellular APP C-terminal domain.
The g-secretase is a complex of four noncovalently
associated protein components that appear to be sufficient for enzymatic
activity. The active site of the complex has been shown to reside in presenilin-1
(PS1) or its closely related isoform PS2, which are predicted to traverse
the membrane eight times. However, for PS1 to attain enzymatic function,
it must associate with three other integral membrane proteins, nicastrin
(NCT), APH-1 and PEN-2. PEN-2 is a 101 amino acid long protein which we
found traverses the membrane twice, with both its C- and N-terminal domains
facing the lumen of the endoplasmic reticulum (ER). APH-1 is predicted
to traverse the membrane seven times. NCT is a type I transmembrane protein
containing multiple glycosylation sites, and has been shown to be essential
for APP processing and Notch signaling. Studies performed in Drosophila
melongaster have shown that NCT appears to stabilize PS1 and to be
critical for trafficking of PS to the cell surface. Conversely, PS1 is
required for the maturation and trafficking of NCT. Much of our work in
this area concerns the structure and function of the g-secretase
complex. How do these 4 proteins interact with each other? What are their
functions? How is the activity of this complex regulated?
KEY WORDS:
Alzheimer's disease, APP, presenilin, HIV-1, SIV, neuropathogenesis, NT2N neurons
Doms Lab

|